FDA Inspection 1234330 — Woodward Pharma Services LLC

Woodward Pharma Services LLC — FEI 3017670223

The FDA completed an inspection of Woodward Pharma Services LLC on Mar 28, 2024 in Wixom, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 28, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wixom, MI (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
673621 CFR 314.80(c)(1)(ii)Submission of report follow-up
683521 CFR 314.80(d)Failure to submit scientific article